Ablynx NV (XBRU:ABLXS) Other Operating Expense : €2.73 Mil (TTM As of Dec. 2017)

View and export this data going back to . Start your Free Trial

What is Ablynx NV Other Operating Expense?

Ablynx NV's Other Operating Expense for the six months ended in Dec. 2017 was €2.77 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2017 was €2.73 Mil.

Ablynx NV's quarterly Other Operating Expense declined from Dec. 2016 (€1.81 Mil) to Jun. 2017 (€-0.05 Mil) but then increased from Jun. 2017 (€-0.05 Mil) to Dec. 2017 (€2.77 Mil).

Ablynx NV's annual Other Operating Expense declined from Dec. 2015 (€-82.42 Mil) to Dec. 2016 (€-99.26 Mil) but then increased from Dec. 2016 (€-99.26 Mil) to Dec. 2017 (€2.73 Mil).

Ablynx NV Other Operating Expense Historical Data

The historical data trend for Ablynx NV's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Other Operating Expense Chart

Ablynx NV Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Other Operating Expense

Get a 7-Day Free Trial

-2.08

-0.91

-82.42

-99.26

2.73

Ablynx NV Semi-Annual Data
	Dec07	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17
Other Operating Expense	Get a 7-Day Free Trial															1.14	-0.39	1.81	-0.05	2.77

Ablynx NV Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2017 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.73 Mil.

Ablynx NV Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ablynx NV (XBRU:ABLXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.ablynx.com

Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines